SILVERARC CAPITAL MANAGEMENT, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Tela Bio, Inc. 13G/A
TELA · 872381108
 4.8% 8/14/2026
Event 6/30/2026
Kalvista Pharmaceuticals, Inc. 13G/A
483497AA1
 0% 8/14/2026
Event 6/30/2026
Elutia Inc. 13G/A
ELUT · 05479K106
 4.9% 8/14/2026
Event 6/30/2026
Cellectar Biosciences Inc 13G
CLRB · 15117F880
 10.0% 8/14/2026
Event 6/30/2026
NextCure, INC. 13G/A
NXTC · 65343E207
 4.9% 5/13/2026
Event 3/31/2026
KalVista Pharmaceuticals Inc 13G
KALV · 483497103
 5.6% 5/13/2026
Event 3/31/2026
Helix Acquisition Corp. III 13G
HLXC · G4444S107
 6.8% 5/13/2026
Event 3/31/2026
Fractyl Health Inc 13G/A
GUTS · 35168W103
 2.3% 5/13/2026
Event 3/31/2026
Avalo Therapeutics, Inc. 13G
AVTX · 05338F306
 2.8% 2/10/2026
Event 12/31/2025
iBio, Inc. 13G
IBIO · 451033708
 10.0% 11/14/2025
Event 9/30/2025
Molecular Templates, Inc. 13G/A
MTEM · 608550208
 0% 2/12/2025
Event 12/31/2024